Amanda Bellanti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amanda Bellanti has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Anastasia Pavlidou
Translational Research Center, University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland
3 shared publications Andreas Meyer-Lindenberg
Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
3 shared publications- Dusan Hirjak
Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
3 shared publications Geva A. Brandt
Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
3 shared publications- Sebastian Walther
Department of Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Würzburg, Germany
3 shared publications Stefan Fritze
Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
3 shared publications
Latest Publications
- Open Access
- 24 August 2026
- Published by Springer Nature in Schizophrenia
- Vol. 12 (1) , 69
Clinical and neurobiological correlates of tardive dyskinesia in schizophrenia spectrum disorders and mood disorders
Tardive dyskinesia (TD) is a persistent sensorimotor syndrome associated with antipsychotic exposure in schizophrenia spectrum disorders (SSD) and mood disorders (MOD), yet its neurobiological basis remains poorly understood. We investigated whether TD represents a distinct clinical and neurobiological phenotype across SSD and MOD. In this study, we examined a bicentric cohort of 453 individuals with SSD ( n = 360) or MOD ( n = 93), including early-psychosis (EP) and multiple-episode SSD patients. TD status was defined using Schooler and Kane criteria based on the Abnormal Involuntary Movement Scale (AIMS). Psychopathology was assessed with the Positive and Negative Syndrome Scale (PANSS). Structural MRI data were processed using FreeSurfer (v7.4.1). Propensity score matching was applied to compare TD-positive and TD-negative patients while controlling for age, sex, illness duration, antipsychotic dose, and PANSS scores. TD prevalence was 10.6% in multiple-episode SSD ( n = 31) and 7.5% in MOD ( n = 7), whereas no EP patients met criteria for TD. Logistic regression identified male sex ( p = 0.005) and higher PANSS general psychopathology scores ( p = 0.021) as independent predictors of TD. TD-positive patients showed reduced paracentral cortical surface area in both the matched SSD sample ( n = 86; p = 0.006, corr.) and the combined transdiagnostic sample ( n = 179; p = 0.024, corr.). These alterations were absent in EP patients. In conclusion, our findings suggest that TD is a transdiagnostic phenomenon, occurring in both SSD and MOD. However, TD in SSD appears to be associated with a distinct clinical and neurobiological phenotype, marked by greater illness severity, male predominance, and focal sensorimotor cortical alterations.
- 24 August 2026
- Published by Springer Nature in Schizophrenia
- Vol. 12 (1) , 69
Open AccessClinical and neurobiological correlates of tardive dyskinesia in schizophrenia spectrum disorders and mood disorders
Tardive dyskinesia (TD) is a persistent sensorimotor syndrome associated with antipsychotic exposure in schizophrenia spectrum disorders (SSD) and mood disorders (MOD), yet its neurobiological basis remains poorly understood. We investigated whether TD represents a distinct clinical and neurobiological phenotype across SSD and MOD. In this study, we examined a bicentric cohort of 453 individuals with SSD ( n = 360) or MOD ( n = 93), including early-psychosis (EP) and multiple-episode SSD patients. TD status was defined using Schooler and Kane criteria based on the Abnormal Involuntary Movement Scale (AIMS). Psychopathology was assessed with the Positive and Negative Syndrome Scale (PANSS). Structural MRI data were processed using FreeSurfer (v7.4.1). Propensity score matching was applied to compare TD-positive and TD-negative patients while controlling for age, sex, illness duration, antipsychotic dose, and PANSS scores. TD prevalence was 10.6% in multiple-episode SSD ( n = 31) and 7.5% in MOD ( n = 7), whereas no EP patients met criteria for TD. Logistic regression identified male sex ( p = 0.005) and higher PANSS general psychopathology scores ( p = 0.021) as independent predictors of TD. TD-positive patients showed reduced paracentral cortical surface area in both the matched SSD sample ( n = 86; p = 0.006, corr.) and the combined transdiagnostic sample ( n = 179; p = 0.024, corr.). These alterations were absent in EP patients. In conclusion, our findings suggest that TD is a transdiagnostic phenomenon, occurring in both SSD and MOD. However, TD in SSD appears to be associated with a distinct clinical and neurobiological phenotype, marked by greater illness severity, male predominance, and focal sensorimotor cortical alterations.
- Open Access
- 31 July 2026
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 56, e250
Replicable subcortical alterations linked to neurological soft signs in schizophrenia spectrum disorders – CORRIGENDUM
- 31 July 2026
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 56, e250
Open AccessReplicable subcortical alterations linked to neurological soft signs in schizophrenia spectrum disorders – CORRIGENDUM
- Open Access
- 6 July 2026
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 56, e212
Replicable subcortical alterations linked to neurological soft signs in schizophrenia spectrum disorders
Background: Neurological soft signs (NSS) are frequent in schizophrenia spectrum disorders (SSD) and have been linked to structural alterations in basal ganglia-thalamic (BGT) regions. We hypothesized that SSD patients would show BGT volume differences compared to healthy controls (HC) and that NSS severity would relate to BGT volume and surface morphology in a replicable pattern. Methods: Structural 3T T1-weighted MRI scans were obtained from 327 SSD patients and 134 matched HC in Mannheim (Germany) and Bern (Switzerland). NSS were assessed using the Heidelberg Scale and the Neurological Evaluation Scale (NES). BGT volumes were segmented using FSL-FIRST and compared across groups using general linear models adjusted for age, sex, intracranial volume, and daily antipsychotic medication. Associations with NSS scores were tested using regression analyses. Results: High-NSS compared to low-NSS SSD patients showed reduced left accumbens volume in both cohorts, with a significant main effect in the Mannheim cohort (β = −43.73, p = .002 uncorrected, p = .019 corrected) and a partial replication in the Bern cohort (β = −53.06, uncorrected p = .03, p > .05, corrected). In contrast, IF-related effects on left accumbens and bilateral thalamic volumes were cohort specific. Daily antipsychotic medication and illness duration did not mediate or moderate these associations. Conclusions: This bicentric MRI study provides converging evidence that NSS severity in SSD is associated with BGT alterations, particularly reduced left nucleus accumbens volume. However, thalamic and surface-level findings were cohort specific, indicating partial rather than uniform reproducibility. Associations were not explained by daily dosage of antipsychotic medication or illness duration.
- 6 July 2026
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 56, e212
Open AccessReplicable subcortical alterations linked to neurological soft signs in schizophrenia spectrum disorders
Background: Neurological soft signs (NSS) are frequent in schizophrenia spectrum disorders (SSD) and have been linked to structural alterations in basal ganglia-thalamic (BGT) regions. We hypothesized that SSD patients would show BGT volume differences compared to healthy controls (HC) and that NSS severity would relate to BGT volume and surface morphology in a replicable pattern. Methods: Structural 3T T1-weighted MRI scans were obtained from 327 SSD patients and 134 matched HC in Mannheim (Germany) and Bern (Switzerland). NSS were assessed using the Heidelberg Scale and the Neurological Evaluation Scale (NES). BGT volumes were segmented using FSL-FIRST and compared across groups using general linear models adjusted for age, sex, intracranial volume, and daily antipsychotic medication. Associations with NSS scores were tested using regression analyses. Results: High-NSS compared to low-NSS SSD patients showed reduced left accumbens volume in both cohorts, with a significant main effect in the Mannheim cohort (β = −43.73, p = .002 uncorrected, p = .019 corrected) and a partial replication in the Bern cohort (β = −53.06, uncorrected p = .03, p > .05, corrected). In contrast, IF-related effects on left accumbens and bilateral thalamic volumes were cohort specific. Daily antipsychotic medication and illness duration did not mediate or moderate these associations. Conclusions: This bicentric MRI study provides converging evidence that NSS severity in SSD is associated with BGT alterations, particularly reduced left nucleus accumbens volume. However, thalamic and surface-level findings were cohort specific, indicating partial rather than uniform reproducibility. Associations were not explained by daily dosage of antipsychotic medication or illness duration.